Background The presence of macroenzymes can cause significant diagnostic confusion and their detection can involve relatively cumbersome analytical procedures.
Introduction
Macroenzymes are enzymes in plasma that have formed high-molecular-mass complexes, either by self-polymerization or by association with other plasma components. 1 They have been described for most routinely measured enzymes in the clinical laboratory, and are usually complexes of normal enzymes with an Ig, although other forms have been reported. 1, 2 Immunoglobulin-associated forms are referred to as type 1 macroenzymes; any others are termed type 2. 2 Although plasma activity may be una¡ected or, perhaps, reduced by such e¡ects, in some cases, Ig binding to circulating enzymes may lead to an increased activity, probably by mechanisms involving reduced inactivation, clearance or excretion. 1 There is little evidence that type 1 macroenzymes indicate the presence of disease. However, they are indistinguishable from normal enzymes during routine assay. The importance of their detection lies in their ability to cause diagnostic confusion when plasma enzyme activities are elevated, leading to unnecessary further investigative procedures. 3, 4 Although prevalence studies are rare, the presence of a macroenzyme is not necessarily uncommon. For example, macroamylase may be detected in approximately one in 20 individuals with hyperamylasaemia. 5 However, techniques to detect macro-enzymes often involve complicated or cumbersome procedures requiring highly specialized chromatography, electrophoresis or ultracentrifugation equipment not available to the average hospital laboratory. 3 A relatively simple technique that has been successfully applied to the detection of macroamylase is that of polyethylene glycol (PEG) precipitation. 5, 6 However, there are virtually no reference range data for any enzyme other than amylase. Hence, the purpose of the present study was to examine the precipitation technique with a view to constructing reference ranges of PEG-precipitable activity (%PPA) for each of seven routinely measured plasma enzymes, where possible, to assess the homogeneity of the various reference groups by isoenzyme electrophoresis, and to report our experiences with the technique in patient investigation. amylase (AMY), creatine kinase (CK), g-glutamyltranspeptidase (GGT), lactate dehydrogenase (LDH), albumin (ALB), total protein (TP), triglycerides (TG), cholesterol (CHOL) and creatinine were carried out using methods and equipment described previously. 7 The upper reference limits for the plasma enzyme activities were: ALT 50 U/L, AST 40 U/L, ALP 140 U/ L, AMY 100 U/L, CK 195 U/L, GGT 50 U/L and LDH 540 U/L. Measurement of Igs G, A and M was performed on a Beckman Array protein system [Beckman Instruments (UK) Ltd, High Wycombe, UK].
Laboratory results were scrutinized in order to identify individuals, generally with elevated plasma enzyme activities, from whom surplus unhaemolysed plasma was retrieved. In each case, using request form information, the data recorded for each patient included age, sex and any clinical details provided. Plasma from individuals known to be of high risk (e.g. human immunode¢ciency virus, hepatitis B or C) were not selected. Reference ranges were constructed by selecting plasma from approximately 40 patients for each enzyme. In order to avoid the possibility of the inadvertent inclusion of samples containing macroenzyme, the homogeneity of each group was assessed by examination of each distribution for the presence of outliers, and, in the case of AST, ALT, ALP, CK and LDH, by subjecting to isoenzyme electrophoresis the four samples showing lowest and the four showing highest %PPA. Any skewed distribution was normalized by logarithmic or square root transformation as required; after appropriate exclusion and investigation of any outliers, reference ranges were calculated as plus and minus two standard deviations (SD) from the mean.
To investigate the PEG precipitation process, pooled human plasma was prepared from blood obtained from patients with elevated Igs. Ten aliquots of this pooled plasma were each mixed with an equal volume of PEG 6000 (240 g/L in 9 g/L saline) and, after vortex mixing, were held variously for 1-10 min at room temperature (218C) prior to centrifugation. Each supernantant was removed, analysed for ALB, TP, TG, CHOL, IgG, IgA and IgM and the results were compared with those obtained from a 1:2 dilution of the pooled plasma in 9 g/L saline.
In the construction of reference ranges for %PPA, patients' plasma (200 mL) was added to either 200 mL of PEG 6000 solution (240 g/L in 9 g/L saline) or 200 mL saline (9 g/L) and held at room temperature for 10 min prior to centrifugation. For each patient, the enzyme activities were measured on both the supernatant and the saline dilution. %PPA was calculated for each enzyme as: %PPAˆ100 £ ‰…activity saline ¡ activity PEG †= …activity saline †Š Inter-assay precision of %PPA measurement was assessed by including a bovine serum-based commercial quality control sample with each batch of analyses (Humatrol N, cat. no. 13511, Human, Taunusstein, Germany).
Isoenzyme electrophoresis for ALP, CK and LDH was performed initially using the Corning-ACI system (Corning Medical, Halstead, UK), and more recently by the Sebia Hydrasys semi-automated electrophoresis system (Sebia, Issy-les-Moulineaux, France). AST and ALT isoenzymes were separated on Corning Universal agarose gels (now available from Helena Biosciences Ltd, Sunderland, UK; cat. no. HL-3-1161SA) and visualized as described by Dawson et al. 8 The AST and ALT isoenzymes were viewed under ultraviolet light (366 nm) as dark bands on a £uorescent background.
Results

Polyethylene glycol precipitation
The results of the study of PEG precipitation on pooled plasma are shown in Table 1 . PEG precipitation removed all of the measurable IgG, IgM and approximately 80% of the IgA, CHOL, TG and GLOB, whereas ALB was little a¡ected. The precipitation process was complete within 1min at room temperature, and further incubation produced no increase in analyte removal.
Reference ranges
The reference data from which the proposed reference ranges were calculated are summariz ed in Table 2 . There were only two outliers, which were excluded from further calculation. One was from the amylase group (%PPAˆ82) of 4.4 SD from the mean. The second outlier arose in the LDH group (%PPAˆ100), which was 4.1 SD above the mean. Isoenzyme electrophoresis of this latter sample revealed a broad band of activity in the LD4-LD3 region typical of macroLDH, 9, 10 as shown schematically, together with the other three highest and four lowest %PPA values, in Fig. 1 . Isoenzyme electrophoresis of AST and ALT yielded only the cytoplasmic isoenzymes; ALP showed only liver and/or bone bands of activity; and CK exhibited only the presence of MM or MM plus MB. The distributions of %PPA for ALP and CK were each positively skewed. These were normaliz ed by square root and logarithmic transformations, respectively.
Precision
The inter-assay coe¤cients of variation for %PPA measurements with the Humatrol N quality control specimen for each of the seven enzymes, over 12 separate batches (six in the case of GGT) are given in Table 3 .
Ann Clin Biochem 2003; 40: 514-520 (14); cancer (10); pancreatic disease (5); chronic renal failure/ bone disease (5); others (9) 278 (122-974) 11.0* (0-40.0) **0-36 AST 40 (15F, 25M) 57 (9-86) Myocardial infarction/chest pain (14); liver disease/alcoholism (16) 
Patients
The screening protocol included both the PEG precipitation test and isoenzyme electrophoresis in each case of ALP, AST, ALT, CK and LDH examined. In the detection of macroamylase, in addition to PEG precipitation, a request was always made to obtain a suitable urine specimen for measurement of the amylase/creatinine clearance ratio (ACCR).
Since introducing the PEG precipitation test we have investigated 57 patients for the presence of macroenzymes. Including the one case (case 1) of macroamylasaemia (macroAMY) and one of macro-LDH (case 9) encountered during the production of reference ranges as described, we have, at time of writing, identi¢ed 12 cases of macroenzymaemia (positives/total tested): ¢ve with macroAMY (5/21); three with macroAST (3/3); one macroLDH (1/3); one typical of type 1 macroCK 1,3 plus one typical of type 2 macroCK 11, 12 (2/18); and one composed mainly of an electrophoretically slow-moving band consistent with macroALP 13, 14 (1/5). No patients have, as yet, been identi¢ed as having macroGGT (0/6) or macroALT (0/1). The positive cases, together with their associated details, including results of ACCR where available, are summarize d in Table 4 . As can be seen from this table, each of these patients showed %PPA values markedly above the proposed upper reference limits. Of the 16 patients considered negative for macroAMY by the PEG precipitation test (median %PPAˆ35, range 24 -47), ACCR results were available for 14 specimens from 13 patients and these were also normal 5 (median ACCRˆ3.8%, range 2.5-13.5%). Isoenzyme electrophoresis was not available as a con¢rmatory test for macroGGT detection. However, electrophoresis was performed on all patients investigated for macroALP, macroALT and macroLDH, and each negative showed %PPA values within the proposed reference ranges. All three patients investigated for the presence of macroAST showed both elevated %PPA and a macroenzyme band on electrophoresis, as described in Table 4 .
Of the 16 patients considered negative for macroCK, three showed %PPA values above the proposed upper reference limit. These were 41.0, 41.4 and 44.0, respectively. An isoenzyme electrophoresis result was unavailable for the ¢rst of these three patients, whereas the other two with higher values for %PPA showed no evidence of the presence of macroCK. The next highest value for CK %PPA was 66.1 (see Table 4 , case 11). This sample was from a 59-year-old gentleman with histologically con¢rmed hepatic metastases from an unknown primary. He manifested a distinctive cathodic band on isoenzyme electrophoresis consistent with the presence of macroCK type 2. 1 Of those shown to be positive for the presence of macroenzymes, some of the case histories are described below.
Case 5
This 31-year-old gentleman was admitted as an emergency with acute abdominal pain, pyrexia and vomiting. He had a 5-year history of Crohn's disease. On admission, his urea and electrolytes, liver function tests, glucose and calcium were normal. His plasma AMY was 1779 U/L (normal 5100 U/L), which was consistent with a presumed diagnosis of acute pancreatitis. However, a subsequent abdominal ultrasound examination was normal and showed no evidence of acute pancreatitis, despite a further elevated plasma AMY activity of 1426 U/L. Nine days after admission his plasma AMY remained at1422 U/L despite an abdominal computed tomography (CT) scan which showed no evidence of pseudocyst formation or pancreatic in£ammation. A urine test for AMY activity showed a result of only 33 U/L, an ACCR of 0.03% (normal 41.6%), 5 and measurement of %PPA on two separate occasions yielded values of 96.6 and 95.5, all of which indicated the presence of macroamylase.
Case 7
This 63-year-old gentleman was admitted to hospital for routine removal of nasal polyps. His admission urea and electrolytes and electrocardiogram (ECG) were normal. Several hours after this operation he was found collapsed. His plasma AST was 240 U/L (normal 540 U/L) with normal CK and ALT; a provisional diagnosis of acute myocardial infarction was made. On the following day his AST was 233 U/L, CK and ALT remained within normal limits, his ECG was unremarkable and he quickly recovered. Retrospective measurement of AST on the blood specimen taken more than 24 h previously, at time of admission, showed a result of 89 U/L. PEG precipitation tests on this specimen and the two subsequent ones yielded %PPA values of 95, 97 and 100, respectively, whilst AST electrophoresis con¢rmed the presence of macroAST as the only visible band of activity. Interestingly, a further test, which was performed 4 years later, showed an AST of 211 U/L; a PEG precipitation of 100% and AST electrophoresis again con¢rmed the presence of persisting macroAST.
Case 8
This 41-year-old lady had been noted to have a mild degree of neutropenia during routine monitoring of her latest pregnancy and was referred to a haematologist who was able to diagnose immune neutropenia by demonstrating the presence of granulocyte -speci¢c antibodies (IgG and IgM) in her serum. However, during her investigations she was noted, over a 3month period, to have signi¢cantly elevated plasma AST activities, of 414, 513 and 411 U/L, respectively, whilst other liver function tests were within normal limits. In response to these ¢ndings, and after delivery of a healthy male infant, an abdominal ultrasound examination was performed which was unremarkable, indicating that the liver, kidneys, spleen and pancreas were normal. Further blood specimens taken 1month later showed an ASTof 602 U/L and a %PPA of 97; AST isoenzyme electrophoresis con¢rmed the presence of macroAST. Moreover, re-measurement of AST on both plasma and serum specimens revealed a marked decrease in activity with time of specimen storage. More than 90% of the original AST activity was lost during 6 days of refrigerated storage. By comparison, a similarly treated control sample from a 54-year-old gentleman with liver disease (plasma AST 174 U/L, %PPA 44, AST isoenzyme electrophoresis exhibiting mainly the anodal cytoplasmic isoenzyme with a small cathodal mitochondrial band and no macroAST) showed virtually no loss of activity over the same period (see Fig. 2 ).
Discussion
Polyethylene glycol precipitation
The PEG precipitation process, as used in the present study, is relatively speci¢c for the globulin fraction of plasma, removing virtually all measurable Ig. The e¡ect is rapid and complete within 1min of incubation at room temperature.
The e¡ects of PEG on plasma enzyme activity are probably multifactorial. Firstly, since Igs are precipitated, any enzyme that is Ig-bound will also be removed, thereby allowing detection of type 1 macroenzymes. Secondly, there is signi¢cant removal of lipid from plasma by PEG and the reagent has been applied successfully to the selective precipitation of LDLs. 15 Some additional forms of type 2 macroenzymes such as GGT or ALP may be composed of lipid aggregates, 1 and hence treatment with PEG may be expected to remove these enzymes along with their attached lipid. Thirdly, treatment of sample with PEG is capable of precipitating macroCK type 2, 11 as observed in case 11 of the present study (see Table 4 ). MacroCK type 2 is thought to represent macromolecular aggregates of mitochondrial CK found in the serum of severely ill patients, mainly those with malignant disease. 16 However, Igs and lipids are not substantial parts of macroCK type 2. 11 Hence, the mechanism and potential variability of reduction in enzyme activity following treatment with PEG in cases of macroCK type 2 remains to be determined. A fourth possible e¡ect of PEG is inhibition of enzyme activity. Even in the absence of macroenzyme, as observed by isoenzyme electrophoresis, there is a wide variation in the reference ranges for %PPA between each enzyme. One possible reason for this may be variable enzyme inhibition. Therefore, application of the test and reference ranges to analytical systems and platforms other than those employed in the present study would require validation. However, notwithstanding the above comments, the PEG precipitation test proved to be a simple technique to perform.
It is not envisaged at the present time that the PEG precipitation test be adopted as a substitute for isoenzyme electrophoresis in the investigation of patients with possible macroenzymes. However, as experience accumulates and, if the technique proves to be free of false negatives, it should readily allow the search for patients with macroenzymes to be conducted more easily. It is interesting that two cases of previously unsuspected macroenzymaemia were discovered incidentally during the construction of reference ranges for %PPA.
Reference ranges
The proposed reference range for AMY %PPA of 22-60, as determined by the present study, is very similar to, and consistent with, the threshold value for further investigation of 57 as proposed in the recent extensive study by Lawson. 5 In the absence of amylase isoenzyme electrophoresis, the additional or con¢rmatory test available to us in the present study was the ACCR. In the ¢ve cases positive for macroamylase shown in Table 4 , ACCR results were available for three patients and these were also abnormal.
It has been recently reported that plasma from four control patients with elevated ALP activities due to liver or bone disease, when mixed with an equal volume of 24% (w/v) PEG 8000, precipitated 5%, 7%, 8% and 17% of the activity; 17 this is consistent with our proposed reference range for %PPA ALP of 0-36. By comparison, in the same report, two samples from a case of macroALP showed values of 73 and 82, respectively; 17 this is in agreement with our own ¢ndings (see Table 4 , case 12).
The number of subjects used to construct each of the reference ranges for %PPA may be considered to be rather small. However, with the gradual accumulation of data, more suitable cut-o¡ values for %PPA, below which the existence of a macroenzyme has proven to be unlikely, should emerge with experience. For example, it is likely that the reference range for %PPA for CK will require some alteration.
Patients
The description of case 5 above is typical of that of a case of macroamylasaemia. However, detection of the presence of macroamylase does not, by itself, necessarily exclude a diagnosis of acute pancreatitis. 5 This appears to have been the situation with case 3 (see Table 4 ). This same argument, that disease may be present, though less likely, despite the existence of a macroenzyme, applies to all individuals in whom one has been detected.
Regarding case 7, that of macroAST, it is noteworthy that the presence of macroenzyme was not a transient phenomenon; hence, it is important to record this information prominently in the patient's notes in order to help avoid diagnostic confusion, perhaps years in the future. The most interesting feature of case 8 is the rapid disappearance of AST activity in vitro following sample collection and separation. Presumably, this is due to the gradual precipitation of enzyme -Ig complex during refrigerated storage. It will be interesting to determine, as experience is accumulated, if this is a common feature of samples containing macroenzymes; if so, the observation may be incorporated into a future testing regime.
